High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis (Q37117971)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 September 2011
edit
Language Label Description Also known as
English
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
scientific article published on 29 September 2011

    Statements

    High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis (English)
    M H Imam
    E Sinakos
    A A Gossard
    K V Kowdley
    V A C Luketic
    M Edwyn Harrison
    T McCashland
    A S Befeler
    D Harnois
    R Jorgensen
    J Petz
    J Keach
    A C DeCook
    F Enders
    K D Lindor
    29 September 2011
    1185-1192

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit